Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04429542 |
Title | Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Bicara Therapeutics |
Indications |
anal canal squamous cell carcinoma thyroid gland anaplastic carcinoma head and neck squamous cell carcinoma |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |